Watch Laser Acupuncture With Nasal Radiation for Prevention of Coronary Artery Disease

February 5, 2019 updated by: Ebtesam Nabil, Cairo University

Laser Hemotherapy Trial for Coronary Artery Disease Prevention in High Risk Patients

This study will evaluate the effect of low level laser blood radiation applied to all participants for prevention of coronary artery disease in patients with high risk (hypertension,high blood viscosity, hypercholesterolemia as well as related immune issues)

Study Overview

Detailed Description

The areas of low - intensity laser use have expanded in several conditions by different mechanisms and ways. Hypertension as one of coronary artery disease risk factors and early indicator of future cardiovascular events with high blood viscosity and elevated blood cholesterol levels with immune-pathological basis became necessary issue to be handled. Low Level Laser irradiation effects on blood is very essential way in revealing the mechanisms of the action of laser radiation on biological tissues by means of changes in metabolism, leading to molecular, cellular and systemic changes.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dokki
      • Giza, Dokki, Egypt, 11432
        • Cairo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

53 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • stage I hypertensive patients
  • patients from 30 to 34.9 kg/m2 body mass index
  • medically stable patients
  • all participants have sufficient cognition enough to understand the requirements of the study

Exclusion Criteria:

  • history of malignant disease
  • smoking
  • history of progressive fatal disease
  • history of drug or alcohol abuse
  • blood donation within at least 30 days
  • pregnant, trying to be pregnant or breast feeding
  • cognitive impairment that will make it difficult to partake in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: low level laser hemotherapy
Watch laser acupuncture and nasal irradiation
semiconductor laser therapeutic instrument irradiate the circulating blood in the vessels of left hand acupoint and the mucosal tissue in the nasal cavity
Other Names:
  • Watch laser
No Intervention: control
all the participants in this group did not receive low level laser irradiation during the study period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes of blood pressure
Time Frame: 8 weeks
measuring blood pressure before and after each low level laser radiation
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in blood viscosity
Time Frame: 8 weeks
measuring changes in blood viscosity before and after low level laser radiation session
8 weeks
change in IL-17 level
Time Frame: 45 days
measuring changes in IL-17 level before and after low level laser radiation session
45 days
change in functional capacity
Time Frame: 70 days
measuring of 6 minute walking test before and after low level laser irradiation as an indicator of functional capacity improving
70 days
change in CD 8 (cluster of differentiation 8) level
Time Frame: 45 days
measuring changes in CD 8 (cluster of differentiation 8) level before and after low level laser radiation session
45 days
change in TC (total cholesterol) level
Time Frame: 60 days
measuring changes in TC (total cholesterol) level before and after low level laser radiation session
60 days
change in LDL (low density lipoprotien) level
Time Frame: 60 days
measuring changes in LDL (low density lipoprotien) level before and after low level laser radiation session
60 days
change in TG (triglyceride) level
Time Frame: 60 days
measuring changes in TG (triglyceride) level before and after low level laser radiation session
60 days
change in HDL (high density lipoprotien) level
Time Frame: 60 days
measuring changes in HDL (high density lipoprotien) level before and after low level laser radiation session
60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cairo Giza, MD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

August 5, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

February 25, 2018

First Submitted That Met QC Criteria

March 3, 2018

First Posted (Actual)

March 6, 2018

Study Record Updates

Last Update Posted (Actual)

February 7, 2019

Last Update Submitted That Met QC Criteria

February 5, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

De-identified participated data for underlie results reported in this trial

IPD Sharing Time Frame

data will be available after 6 months of study completion and ending 36 months

IPD Sharing Access Criteria

proposals should directed to Dr.EbtesamNagy@cu.edu.eg. To gain access, data requestors will need to sign a data access agreement

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on low level laser hemotherapy

3
Subscribe